Toggle navigation
About
About The ASCO Post
Editorial Board
Rights and Permissions
Contact
Subscribe
News
FDA Update
Journal Spotlight
Expert's Corner
In the Clinic
View By Issue
View All
Meetings
ASCO Breakthrough 2026
ASCO 2026
ESTRO 2026
AACR 2026
EBCC15
Calendar
View All
Topics
AI in Oncology
Breast Cancer
Lung Cancer
Prostate Cancer
Lymphoma
Cardio-oncology
View All
Videos
Newsreels
Video Roundtables
Podcasts
Subscribe
Advertisement
Advertisement
Education in Oncology,Education in Oncology
Advertisement
Advertisement
Aug
18
Today In Oncology
Overall Survival With Ivonescimab or Tislelizumab Plus Chemotherapy in Advanced Squamous NSCLC
Proton Pump Inhibitor, Antibiotic Exposure Linked to Inferior Durvalumab Outcomes in Unresectable Stage III NSCLC
Rezatapopt Shows Activity in TP53 Y220C–Mutated Advanced Ovarian Cancer
Sugar- vs Artificially Sweetened Beverages and Gastric Cancer Risk
High-Risk ERBB2-Negative Breast Cancer Adding Dual Checkpoint Blockade to Neoadjuvant Chemotherapy
View More
Advertisement
